The potential of positron-emission tomography to study anticancer-drug resistanceCitation formats

Standard

The potential of positron-emission tomography to study anticancer-drug resistance. / West, Catharine M L; Jones, Terry; Price, Pat.

In: Nature Reviews Cancer, Vol. 4, No. 6, 06.2004, p. 457-469.

Research output: Contribution to journalArticle

Harvard

West, CML, Jones, T & Price, P 2004, 'The potential of positron-emission tomography to study anticancer-drug resistance', Nature Reviews Cancer, vol. 4, no. 6, pp. 457-469.

APA

West, C. M. L., Jones, T., & Price, P. (2004). The potential of positron-emission tomography to study anticancer-drug resistance. Nature Reviews Cancer, 4(6), 457-469.

Vancouver

West CML, Jones T, Price P. The potential of positron-emission tomography to study anticancer-drug resistance. Nature Reviews Cancer. 2004 Jun;4(6):457-469.

Author

West, Catharine M L ; Jones, Terry ; Price, Pat. / The potential of positron-emission tomography to study anticancer-drug resistance. In: Nature Reviews Cancer. 2004 ; Vol. 4, No. 6. pp. 457-469.

Bibtex

@article{f7d7b7391b304ac8bbca299c9c04ec7a,
title = "The potential of positron-emission tomography to study anticancer-drug resistance",
abstract = "Positron-emission tomography (PET) is a powerful tool for imaging and quantifying cellular and molecular processes in humans. It has enormous potential to increase our understanding of the pathophysiology of human tumours and to support the development of anticancer drugs. The ability of PET to image mechanisms of anticancer-drug resistance in vivo should be exploited in proof-of-concept studies at early stages of drug development.",
keywords = "pharmacokinetics: Antineoplastic Agents, Drug Resistance, Neoplasm, Humans, physiopathology: Neoplasms, Tomography, Emission-Computed",
author = "West, {Catharine M L} and Terry Jones and Pat Price",
year = "2004",
month = "6",
language = "English",
volume = "4",
pages = "457--469",
journal = "Nature Reviews. Cancer",
issn = "1474-1768",
publisher = "Springer Nature",
number = "6",

}

RIS

TY - JOUR

T1 - The potential of positron-emission tomography to study anticancer-drug resistance

AU - West, Catharine M L

AU - Jones, Terry

AU - Price, Pat

PY - 2004/6

Y1 - 2004/6

N2 - Positron-emission tomography (PET) is a powerful tool for imaging and quantifying cellular and molecular processes in humans. It has enormous potential to increase our understanding of the pathophysiology of human tumours and to support the development of anticancer drugs. The ability of PET to image mechanisms of anticancer-drug resistance in vivo should be exploited in proof-of-concept studies at early stages of drug development.

AB - Positron-emission tomography (PET) is a powerful tool for imaging and quantifying cellular and molecular processes in humans. It has enormous potential to increase our understanding of the pathophysiology of human tumours and to support the development of anticancer drugs. The ability of PET to image mechanisms of anticancer-drug resistance in vivo should be exploited in proof-of-concept studies at early stages of drug development.

KW - pharmacokinetics: Antineoplastic Agents

KW - Drug Resistance, Neoplasm

KW - Humans

KW - physiopathology: Neoplasms

KW - Tomography, Emission-Computed

M3 - Article

VL - 4

SP - 457

EP - 469

JO - Nature Reviews. Cancer

JF - Nature Reviews. Cancer

SN - 1474-1768

IS - 6

ER -